Aortic Valve Stenosis ECG Screening Market

Resting ECG screening leads the aortic valve stenosis ECG screening market with a 33.2% share in 2026, while hospitals account for 41.5% by end user. Market growth depends on earlier cardiovascular screening, AI-enabled ECG analysis, and specialist referral pathways, while diagnostic accuracy, confirmatory imaging, and clinical workflow integration remain essential for broader adoption.